Atlas Venture Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $5.33M | Hold |
|
|||||
|
2022
Q4 | $6.12M | Hold |
|
|||||
|
2022
Q3 | $4.3M | Hold |
|
|||||
|
2022
Q2 | $2.42M | Hold |
|
|||||
|
2022
Q1 | $3.87M | Hold |
|
|||||
|
2021
Q4 | $4.14M | Hold |
|
|||||
|
2021
Q3 | $3.45M | Hold |
|
|||||
|
2021
Q2 | $3.83M | Hold |
|
|||||
|
2021
Q1 | $3.5M | Hold |
|
|||||
|
2020
Q4 | $3.45M | Hold |
|
|||||
|
2020
Q3 | $2.45M | Hold |
|
|||||
|
2020
Q2 | $3.49M | Hold |
|
|||||
|
2020
Q1 | $1.41M | Hold |
|
|||||
|
2019
Q4 | $1.51M | Hold |
|
|||||
|
2019
Q3 | $2.3M | Hold |
|
|||||
|
2019
Q2 | $6.44M | Hold |
|
|||||
|
2019
Q1 | $8.77M | Hold |
|
|||||
|
2018
Q4 | $9.52M | Buy |
|